NEWS
- Targeted Therapies for Systemic Lupus Erythematosus (SLE)
- Positive Trial Results of Semaglutide for MASH
- Claudin 18.2: A Promising New Target for Breakthrough Cancer Treatments
- Monodisperse (Discrete) PEGylation vs. Polydisperse PEGylation: Future Trends
- Anticipating FDA Approval: Three Game-Changing Drugs in Q4 2024
- FDA Approves Palopegteriparatide for Hypoparathyroidism
- Upcoming GLP-1 RAs for NASH: A Comprehensive List
- Emerging Trends in the Development of GLP-1 Receptor Agonists
- Radionuclide Drug Conjugates (RDCs): Current Status
- The Difference Between Monodisperse and Polydisperse Polymers